ABSA: C.DIFF GLP Study
This paper addresses the issues of getting a hospital disinfectant approved by the EPA, some of the challenges encountered and results achieved for a number of hospital related pathogens including MRSA, Pseudomonas sp., H1N1, etc. using a novel approach. The paper also addresses the differences between hands-free and wipes technologies, sprays, and their approval pathways.
The paper presents the results from Good Laboratory Practice Studies (GLP) submitted to EPA for a novel technology using The SteraMistTM Surface and Environmental systems. SteraMistTM Binary Ionization Technology® (BITTM), (TOMI, Beverly Hills, CA), converts a 7.8% hydrogen peroxide solution into a Hydroxyl Radical mist. This EPA registered solution is passed through an atmospheric cold plasma arc where activation occurs.
Complete the form below to download the white paper.
Confidence in Cannabis Sterilization
A case study with Sticky SaguaroWith the cannabis industry facing rising popularity and stricter federal sanitation standards, Sticky Saguaro – a cannabis dispensary in Chandler, AZ – looked to take steps to streamline its already-exhaustive cleaning process. In order to comprehensively disinfect…
Redefining Enclosure Decontamination
Advancing Enclosure Decontamination with SteraMist iHP TechnologyEnclosure sterilization has been saturated by traditional methods like Ethylene Oxide (EtO), chlorine dioxide, and high-concentration vaporized hydrogen, but they come with their own set of challenges. EtO regulations have been at a…
Decon On Demand
Deploying iHP® Decontamination ServiceWhether addressing emergency containment, routine shutdowns, facility decommissioning, disaster remediation, or mold spore elimination, SteraMist iHP Corporate Service is ready to deploy at a moment’s notice with a decontamination fogging service.SteraMist…